Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

127120.KQ

STRONG SELL

JS Link, Inc. · Healthcare · South Korea · $779M · Avg Vol: $5M/d

14
StockRank
Q
24
V
21
M
52
P/E (TTM)
ROE
-26.3%
D/E
0.5x
Dividend %

COMPANY DESCRIPTION

JS Link, Inc., a genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue11.2M14.4M10.5M12.7M4.4%
EPS-0.15-0.21-0.36-0.40
Shares34.5M18.7M22.5M34.1M-1.2%
Debt4.0M2.8M12.6M28.5M92.3%
Equity18.4M17.3M16.5M45.2M35.0%
Op CF0.6M-3.3M-4.5M-6.2M
Inv CF-1.8M-2.4M-12.3M-22.0M
Fin CF4.4M3.0M15.5M51.6M
Loading...
PRICE (1Y)-13.7%
20.7022.6724.6426.6028.57May 7May 29Jun 19
SMA 50SMA 200
Close
$23.37
RSI (14)
39.7
52W High
$32.85
From 52W High
0.7%

SCORE BREAKDOWN

Quality
24
ROIC
-19.1%28.6
ROE
-26.3%27.3
GP/Assets
3.5%16.5
Op. Margin
-199.9%13.8
FCF/Assets
-34.8%7.1
Piotroski
430.4
Int. Cover
-6.7x26.4
D/E Ratio
0.49x32.1
Current Ratio
1.72x30.9
Value
21
P/E (TTM)
N/A
EV/EBITDA
-107.1x25.0
P/FCF
N/A
P/B
16.3x6.4
P/S
57.7x9.5
Div Yield
N/A
Momentum
52
52W High %
71%58.6
RS 6M
-28%45.7
SMA 50/200
1.42x96.9
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
N/A

FUNDAMENTALS

Market Cap
$779M
P/E (Forward)
Gross Margin
21.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 127120.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
127120.KQJS Link, Inc.(you)$779M14STRONG SELL
005690.KSPharmicell Co., Ltd.$598M14STRONG SELL
476830.KQRznomics$846M8STRONG SELL
397030.KQAprilBio Co.,Ltd.$621M10STRONG SELL
085660.KQChabiotech Co.,Ltd.$595M10STRONG SELL
475830.KQOrum Therapeutics, Inc.$865M4STRONG SELL
048410.KQHyundai Bioscience Co., Ltd.$578M7STRONG SELL
115180.KQQurient Co., Ltd.$614M2STRONG SELL
475960.KQTOMOCUBE$325M12STRONG SELL
174900.KQAbClon Inc.$477M4STRONG SELL

Peer medians: ROE -1.1% · P/E 17.7x · Gross margin 43.6%

JS Link, Inc. (127120.KQ) — Stock Score Summary

JS Link, Inc. (127120.KQ) has a MoatMap StockRank of 14/100 based on Quality (24/100), Value (21/100), and Momentum (52/100) factor scores. The current signal is STRONG SELL.

JS Link, Inc., a genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.

Key Financial Metrics

Price$23.37
Market Cap$779M
Price/Book16.30
Return on Equity-26.3%
Return on Invested Capital-19.1%
Debt/Equity48.87
Gross Margin21.1%
Operating Margin-199.9%
Revenue Growth69.4%
Free Cash Flow$-19K

JS Link, Inc. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is JS Link, Inc.’s (127120.KQ) StockRank?
MoatMap’s StockRank for JS Link, Inc. (127120.KQ) is 14/100, with a Strong Sell signal. It is a composite of Quality (24), Value (21), and Momentum (52) factor ranks across MoatMap’s 20,000+ stock universe.
Does JS Link, Inc. have an economic moat?
JS Link, Inc. (127120.KQ) has a Quality factor score of 24/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is JS Link, Inc. a buy, hold, or sell?
MoatMap’s current signal for JS Link, Inc. (127120.KQ) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is JS Link, Inc. in?
JS Link, Inc. (127120.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).